Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies

Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies

Item
http://www.wikidata.org/entity/Q27027243
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaAntigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T CellsHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferT cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cellsTransferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy.An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.Immunotherapy highlights from the 2011 meeting of the American Society of Hematology.Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients.T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.Broadening the translational immunology landscape.
P2860

Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies

Item
http://www.wikidata.org/entity/Q27027243
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immunology in the clinic revie ...... fective cancer immunotherapies
@ast
Immunology in the clinic revie ...... fective cancer immunotherapies
@en
Immunology in the clinic revie ...... fective cancer immunotherapies
@nl
type
label
Immunology in the clinic revie ...... fective cancer immunotherapies
@ast
Immunology in the clinic revie ...... fective cancer immunotherapies
@en
Immunology in the clinic revie ...... fective cancer immunotherapies
@nl
prefLabel
Immunology in the clinic revie ...... fective cancer immunotherapies
@ast
Immunology in the clinic revie ...... fective cancer immunotherapies
@en
Immunology in the clinic revie ...... fective cancer immunotherapies
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Immunology in the clinic revie ...... fective cancer immunotherapies
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2249.2011.04517.X
P407
P433
P478
P50
P577
P5875
P698
P921
P932